IONQ insider sales total ~$228M in June; 85,510 shares to be sold Aug 15

Rhea-AI Filing Summary

IonQ Form 144 summary: This notice reports that 85,510 shares of IonQ common stock, acquired on 08/14/2025 upon vesting of equity awards, are proposed for sale through E-TRADE on or about 08/15/2025. The filing shows the company has 296,841,308 shares outstanding and places an aggregate market value on the planned sale of $3,523,868. The filer also disclosed multiple recent sales by the same person during June 2025 totaling several million shares with gross proceeds of approximately $228,225,951.06 across four transactions. The filer attests there is no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Significant insider disposition activity in June and a planned post-vesting sale may be notable but not necessarily material to the company’s overall capitalization.

The filing documents a planned sale of 85,510 vested shares (aggregate value shown as $3.52M) and reports prior insider sales in June 2025 totaling about 5,986,209 shares with gross proceeds of roughly $228.2M. Against an outstanding share count of 296.8M, the cumulative June sales represent a modest percentage of outstanding shares (~2%). From a market-impact perspective, these transactions indicate insider liquidity but do not by themselves reveal operational issues; they are sales of already-acquired equity rather than new issuances.

Corporate Governance Expert

TL;DR: Multiple large sales by a single insider warrant governance attention though the filing contains standard disclosures and no adverse statements.

The Form 144 confirms the seller represented no undisclosed material adverse information and that the 85,510 shares for sale were acquired by vesting of equity awards. The large June dispositions should prompt review of any trading plans or potential Rule 10b5-1 arrangements, but this filing does not state whether such a plan exists. Disclosure is consistent with Rule 144 requirements; however, investors and board committees may request clarity on whether the sales followed pre-established trading plans.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-TRADE Financial Corporation PO Box 484 Jersey City NJ 07303-0484	85510	3523868	296841308	08/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/14/2025	Vesting of equity awards - See Remarks	Issuer			85510	08/14/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Peter Hume Chapman c/o IonQ, Inc. 4505 Campus Drive COLLEGE PARK MD 20740	Common Stock	06/20/2025	1497311	59789125.54
Peter Hume Chapman c/o IonQ, Inc. 4505 Campus Drive COLLEGE PARK MD 20740	Common Stock	06/17/2025	910740	34406573.24
Peter Hume Chapman c/o IonQ, Inc. 4505 Campus Drive COLLEGE PARK MD 20740	Common Stock	06/16/2025	3581193	136536564.32
Peter Hume Chapman c/o IonQ, Inc. 4505 Campus Drive COLLEGE PARK MD 20740	Common Stock	06/11/2025	11965	497688.96

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)